Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
October 27, 2026
HSV and cancer: What patients should know
Cancer treatments can weaken immunity and trigger herpes simplex reactivation, but patients can take protective steps
Fred Hutch researchers look at longevity in older women, metabolic signatures of vaginitis
Two prestigious R01 NIH grants awarded to Drs. Alex Reiner, Sujatha Srinivasan
Exploring the health impacts of sickle cell trait
A new analysis could expand our understanding of the health conditions associated with a single copy of the sickle cell beta globin gene
Unraveling how immune aging influences health outcomes for survivors of childhood blood cancers
Fred Hutch pediatric immunologist’s R01 will support search for therapeutic targets to stave off cardiovascular disease and other aging-associated conditions
Nextstrain virus-tracking platform moves into new phase
Dr. JT McCrone will oversee Gates Foundation-funded efforts to further empower users
Two Fred Hutch postdocs receive prestigious Damon Runyon awards
The early-career scientists will study the biology of acute myeloid leukemia and how certain treatments can make immunocompromised cancer patients more vulnerable to lung infections
Fred Hutch researchers receive prestigious R01 awards
NIH-funded awards will support multi-year investigations into HIV reservoirs, biomarkers of vaccine efficacy and how PrEP influences antibody pharmacokinetics
How Fred Hutch scientists tackle world’s top infectious killer, TB
Expertise in immunology and biostatistics underpin foundational work in tuberculosis vaccines, biomarkers and pathology that could usher in a new era
Giving CAR T cells a portable pit crew
Fred Hutch scientists dig deep into the biology of CAR T-cell exhaustion and examine experimental strategy to improve the immunotherapy for solid tumors
New long-term analysis suggests follicular lymphoma can be cured
The findings could change patient and provider expectations and influence how patients are followed after treatment
Dr. Elizabeth Halloran, expert in vaccine trial design and quantitative methods for infectious diseases, transitions to emerita
Infectious disease modeling pioneer helped outline modern precepts for design and analysis of vaccine trials, causal inference with interference; shaped a generation of infectious disease scientists
The benefits of HIV research? Let us count the ways
HIV work has helped shape the FDA, provided drugs for other infections, changed health systems globally and more, say Fred Hutch experts
‘I can’t remember the last time I saw someone with bad gut GVHD’: BMT expert reflects on recent lifesaving successes
Fred Hutch bone marrow transplant and GVHD expert Dr. Geoffrey Hill explains how a new approach has changed the BMT landscape, where research is headed next
Scientists see foam as starting point of a path to bedside gene therapy
Bioengineer Dr. Matthias Stephan developed a quick-foaming solution that he hopes could one day turn gene therapy into an outpatient procedure
Viral immunologist taps ‘incredible potential’ of immune system
Dr. Paul Thomas will combine computational and empirical approaches to understand the immune repertoire and turn this knowledge into new diagnostic and therapeutic tools
Two lifetimes’ worth of bone marrow transplant breakthroughs
Bone marrow transplant pioneer Dr. Rainer Storb retires and reflects on six decades of science and mentorship
New horizons in infectious disease treatment and prevention in immunocompromised patients
The 5th Symposium on Infectious Disease in the Immunocompromised Host emphasized new opportunities, next generation
Dr. Peter Gilbert receives Marvin Zelen Leadership Award in Statistical Science
Award recognizes leadership in HIV vaccine trial development, analysis
RNA “typos” can highlight leukemia cells for immune attack
Looking beyond DNA, scientists find possible “surgically targeted” option for splicing factor-mutant blood cancers that lack effective immunotherapies
Drs. Keith Jerome and Jesse Bloom elected fellows of American Academy of Microbiology
Fred Hutch researchers’ study of viruses evolves from basic understanding to practical applications